Drug recall D-0058-2023
Product
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).
Reason for recall
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Lots and codes
Lot #: AJ21002, Exp. 03/2024
Recall details
- Recalling firm
- Viatris Inc, Canonsburg, PA
- Quantity
- 22400 syringes
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 7, 2022
- Terminated
- January 12, 2024
Related products
- Octreotide Acetate – drug information
- NDC 67457-245 Octreotide Acetate · Octreotide Acetate 100 ug/mL · Mylan Institutional LLC
- NDC 67457-239 Octreotide Acetate · Octreotide Acetate 50 ug/mL · Mylan Institutional LLC
- NDC 67457-246 Octreotide Acetate · Octreotide Acetate 500 ug/mL · Mylan Institutional LLC